Intravenous bisphosphonate therapy and atrial fibrillation/flutter risk in cancer patients: a nationwide cohort study

BACKGROUND: There is conflicting evidence regarding bisphosphonates and atrial fibrillation (AF) risk in osteoporosis patients. However, bisphosphonates are used in much higher doses in treatment of bone metastasis and hypercalcemia, but little is known about the AF risk in cancer patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Erichsen, R, Christiansen, C F, Frøslev, T, Jacobsen, J, Sørensen, H T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185951/
https://www.ncbi.nlm.nih.gov/pubmed/21878939
http://dx.doi.org/10.1038/bjc.2011.338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185951/
https://www.ncbi.nlm.nih.gov/pubmed/21878939
http://dx.doi.org/10.1038/bjc.2011.338

Ejemplares similares